跳至主要内容
临床试验/JPRN-UMIN000008427
JPRN-UMIN000008427已完成未知

Evaluation of efficacy of rebamipide ophthalmic suspension in patients with dry eye associated with Sjogren's syndrome. - Evaluation of efficacy of rebamipide ophthalmic suspension in patients with dry eye associated with Sjogren's syndrome.

Kanazawa Medical University0 个研究点目标入组 30 人开始时间: 2012年7月13日最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Patients with concomitant anterior eye disease other than dry eye. 2.Patients who have used rebamipide ophthalmic suspension within two weeks prior to the start of the study. 3.Patients who are anticipated to change their eye drop (prescription or OTC medication) during the study. 4.Patients who cannot discontinue use of contact lenses during the study. 5.Patients who inserted punctal plugs or underwent surgical punctal occlusion within one month. 6.Patients who are pregnant, suspected to be pregnant or breastfeeding. 7.Patients who are hypersensitive to the ingredients of the study drug and/or test reagents for this study. 8.Patients who are judged to be ineligible for the study for complications and/or history of systemic disease. 9.Patients who are considered to be inapproriate by the investigators.

研究者

相似试验

Evaluation of efficacy of rebamipide ophthalmic... | 临床试验